AN2 Therapeutics to Participate in 9th Annual Evercore Healthcare Conference
Business Wire•20/11/2026•16:04 ET
0
Key Highlights
- ➤AN2 Therapeutics (ANTX) CEO Eric Easom will join Evercore Healthcare Conference fireside chat
- ➤Fireside chat scheduled for December 2, 2026, at 8:20am ET
- ➤Management will hold one-on-one meetings with investors during the conference
Expert Statements
Eric Easom, Co-Founder, Chairman, President and CEO of AN2 Therapeutics
“will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on Wednesday, December 2, 2026 at 8:20am ET”
AN2 Therapeutics to Participate in 9(th) Annual Evercore Healthcare Conference
AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will participate in a fireside chat at the 9(th) Annual Evercore Healthcare Conference on Wednesday, December 2, 2026 at 8:20am ET and members of management will be available for 1x1 meetings.
Get started
Create a free account to read the full story.
